Table 5.
Treatment emergent adverse events occurring in ≥2% of subjects treated with alprazolam ODT in combination with an SSRI or SNRI or an SSRI/SNRI alone
SSRI/SNRI plus alprazolam ODT N=71 | SSRI/SNRI alone N=71 | |||
---|---|---|---|---|
n | % | n | % | |
Fatigue | 5 | 7.0% | 1 | 1.4% |
Headache | 4 | 5.6% | 4 | 5.6% |
Nausea | 3 | 4.2% | 2 | 2.8% |
Somnolence | 3 | 4.2% | 0 | 0 |
Dry Mouth | 3 | 4.2% | 0 | 0 |
Constipation | 2 | 2.8% | 2 | 2.8% |
Diarrhea | 2 | 2.8% | 1 | 1.4% |
Dizziness | 2 | 2.8% | 1 | 1.4% |
Dysgeusia | 2 | 2.8% | 0 | 0 |